Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2021-09-30 2021-10-07 146440
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86972
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093
CINQAIR 10MG SOLUTION Resolved 2020-05-08 2020-09-03 114421
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-06-27 2019-08-29 87665
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-01-15 2021-05-06 131691
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-02-05 2021-04-29 133457
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-06-24 2021-07-09 141469
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-04-27 2023-06-09 190671
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-06-16 2023-08-18 195121
DOCETAXEL INJECTION 20MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1680
DOCETAXEL INJECTION 80MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1688
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-06-18 2020-06-25 118253
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-10-22 2020-11-12 126918

Showing 341 to 360 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598

Showing 81 to 100 of 250